Vaxigrip
Vaxigrip is a pharmaceutical drug with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza
Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine
Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control
Immunogenicity and Safety Study of Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI)
The Immune Response to Influenza Vaccinations in Elderly Individuals
Clinical Trials (9)
Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza
Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine
Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control
Immunogenicity and Safety Study of Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI)
The Immune Response to Influenza Vaccinations in Elderly Individuals
A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine
Comparison of 4 Influenza Vaccines in Seniors
Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults
Routes of Immunization and Flu Immune Responses
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9